Compare FDMT & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | CHCT |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.9M | 410.6M |
| IPO Year | 2020 | 2015 |
| Metric | FDMT | CHCT |
|---|---|---|
| Price | $9.48 | $18.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $34.13 | $18.50 |
| AVG Volume (30 Days) | ★ 728.1K | 224.3K |
| Earning Date | 02-27-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 10.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $120,000.00 | ★ $119,547,000.00 |
| Revenue This Year | $21,227.03 | $7.32 |
| Revenue Next Year | $161.87 | $6.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 605.88 | 3.40 |
| 52 Week Low | $2.24 | $13.23 |
| 52 Week High | $12.34 | $20.28 |
| Indicator | FDMT | CHCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 63.43 |
| Support Level | $8.75 | $17.41 |
| Resistance Level | $9.78 | $18.20 |
| Average True Range (ATR) | 0.63 | 0.44 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 83.00 | 83.17 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.